Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer
非小细胞肺癌患者在接受皮质类固醇和二线免疫抑制剂治疗后出现免疫相关不良事件时，检查点抑制剂的疗效
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.106052
van Dijk, E J; Smeenk, M M; Bensch, F; Sadowska, A M; Verschueren, M V; Verhaert, M; Llobell, A; Suzuki, Y; Liew, D F L; Takeji, A; Maria, A T J; Peters, B J M; Garcia Morillo, J S; Chatzidionysiou, K; Lidar, M; van der Hout, E C; Aspeslagh, S; Herder, G J M; van de Garde, E M W; Hendriks, L E L; Hijmering-Kappelle, L B M; Theelen, W S M E; Suijkerbuijk, K P M; Verheijden, R J
Checkpoint
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
